全文获取类型
收费全文 | 18107篇 |
免费 | 1205篇 |
国内免费 | 834篇 |
专业分类
耳鼻咽喉 | 146篇 |
儿科学 | 306篇 |
妇产科学 | 439篇 |
基础医学 | 1840篇 |
口腔科学 | 378篇 |
临床医学 | 1937篇 |
内科学 | 3597篇 |
皮肤病学 | 223篇 |
神经病学 | 1516篇 |
特种医学 | 757篇 |
外国民族医学 | 3篇 |
外科学 | 2909篇 |
综合类 | 1558篇 |
现状与发展 | 8篇 |
预防医学 | 772篇 |
眼科学 | 305篇 |
药学 | 1179篇 |
9篇 | |
中国医学 | 318篇 |
肿瘤学 | 1946篇 |
出版年
2024年 | 65篇 |
2023年 | 1184篇 |
2022年 | 1818篇 |
2021年 | 1718篇 |
2020年 | 1844篇 |
2019年 | 888篇 |
2018年 | 619篇 |
2017年 | 739篇 |
2016年 | 799篇 |
2015年 | 746篇 |
2014年 | 1499篇 |
2013年 | 988篇 |
2012年 | 807篇 |
2011年 | 664篇 |
2010年 | 872篇 |
2009年 | 758篇 |
2008年 | 337篇 |
2007年 | 470篇 |
2006年 | 388篇 |
2005年 | 395篇 |
2004年 | 318篇 |
2003年 | 283篇 |
2002年 | 208篇 |
2001年 | 234篇 |
2000年 | 130篇 |
1999年 | 195篇 |
1998年 | 164篇 |
1997年 | 138篇 |
1996年 | 138篇 |
1995年 | 112篇 |
1994年 | 78篇 |
1993年 | 63篇 |
1992年 | 43篇 |
1991年 | 39篇 |
1990年 | 33篇 |
1989年 | 37篇 |
1988年 | 48篇 |
1987年 | 47篇 |
1986年 | 46篇 |
1985年 | 22篇 |
1984年 | 34篇 |
1983年 | 16篇 |
1982年 | 28篇 |
1981年 | 38篇 |
1980年 | 11篇 |
1979年 | 4篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1974年 | 3篇 |
1973年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
《Clinical genitourinary cancer》2022,20(3):e217-e226
Background: Intraductal carcinoma and cribriform (IDC/C) tumor features are well-established prognosticators of biochemical recurrence (BCR), metastasis, and prostate cancer (PCa)-specific mortality. However, approximately 70% of PCa patients undergoing a radical prostatectomy are IDC/C negative, yet up-to 20% of these patients progress and experience BCR. Thus, tumor histopathologic characteristics such as IDC/C alone are limited in their ability to predict disease progression. Conversely, several nomograms such as Cancer of the Prostate Risk Assessment-Surgery (CAPRA-S) have been developed to aid in the prognostication of BCR, but not yet widely applied in clinical settings. Materials and methods: In this study, we assessed the combined prognostic utility of IDC/C, and CAPRA-S for BCR in 3 PCa patient cohorts. Results: CAPRA-S+IDC/C improved the predictive accuracy of BCR in all 3 cohorts (P < .001). Specifically, among IDC/C negative cases, CAPRA-S improved the prognostication of BCR in low-risk (Cohort 1; P < .001, Cohort 2; P < .001, Cohort 3; P = .003), intermediate (Cohort 1; P < .001, Cohort 2; P = .006, Cohort 3; P = .03) and high-risk (Cohort 1-3; P < .001) patients. Conversely, IDC/C improved the prognostication of BCR among CAPRA-S low-risk (Cohorts 1; P < .001 and Cohort 3; P = .003) patients. Conclusion: Our results suggest the investigation of histopathological IDC/C features in CAPRA-S low-risk patients and conversely, nomogram CAPRA-S among IDC/C negative patients improves the identification of patients likely to experience BCR, which would otherwise be missed through current assessment regimens. These patients can be offered more intensive monitoring and adjuvant therapies upfront to circumvent the development of recurrent cancer or overtreatment at the time of surgery. 相似文献
5.
《Vaccine》2019,37(31):4382-4391
Cancer-associated fibroblasts (CAFs), major components of the tumor microenvironment (TME), promote tumor growth and metastasis and inhibit the anti-tumor immune response. We previously constructed a DNA vaccine expressing human FAPα, which is highly expressed by CAFs, to target these cells in the TME, and observed limited anti-tumor effects in the 4T1 breast cancer model. When the treatment time was delayed until tumor nodes formed, the anti-tumor effect of the vaccine completely disappeared. In this study, to improve the safety and efficacy, we constructed a new FAPα-targeted vaccine containing only the extracellular domain of human FAPα with a tissue plasminogen activator signal sequence for enhanced antigen secretion and immunogenicity. The number of CAFs was more effectively reduced by CD8+ T cells induced by the new vaccine. This resulted in decreases in CCL2 and CXCL12 expression, leading to a significant decrease in the ratio of myeloid-derived suppressor cells in the TME. Moreover, when mice were treated after the establishment of tumors, the vaccine could still delay tumor growth. To facilitate the future application of the vaccine in clinical trials, we further optimized the gene codons and reduced the homology between the vaccine and the original sequence, which may be convenient for evaluating the vaccine distribution in the human body. These results indicated that the new FAPα-targeted vaccine expressing an optimized secreted human FAPα induced enhanced anti-tumor activity by reducing the number of FAPα+ CAFs and enhancing the recruitment of effector T cells in the 4T1 tumor model mice. 相似文献
6.
7.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):150-154.e2
Thoracic endovascular aortic repair (TEVAR) for aneurysmal chronic dissection is often complicated by retrograde filling of the false lumen and dissected distal landing zone. A “cheese wire”-style fenestration of the dissection intimal flap can create a landing zone facilitating TEVAR. This technique successfully aided TEVAR in 3 patients with an average age of 57.3 years. Complications included type III endoleak requiring relining and renal artery occlusion requiring stent placement. Average duration of clinical follow-up was 19 ± 4 months. Imaging follow-up was 8 ± 10 months. All patients have survived for more than 1 year without aneurysm enlargement. 相似文献
8.
9.
10.